What Impact is Lead-Time Reduction Having on the End-to-End Pharma Supply Chain?
Antoine du Sartel, Director of Global Supply Chain at Merck Serono, speaks to Andrea charles from Pharma IQ, about the impact lead-time reduction is having on the end-to-end pharma supply chain and the steps we should take to ensure end-to-end supply chain optimisation. He also shares his top 3 tips for preparing the supply chain to respond to a dynamic market and insights on how to identify the KPIs necessary to support increased effectiveness in your supply chain.&nb...
To continue reading this story get free access
Please note: That all fields marked with an asterisk (*) are required.